Skip to main content
main-content

The independent medical news service

26-03-2019 | Oncology | News | Article

Pachymeningeal seeding possible after brain metastases resection

Neurosurgical resection of brain metastases followed by stereotactic radiation can lead to pachymeningeal seeding outside of the stereotactic radiation field, according to findings reported in JAMA Oncology.

27-08-2018 | Oncology | News | Article

Bevacizumab strikes out in recurrent glioma

The outcomes of patients with a first recurrence of WHO grade II or III glioma without the 1p/19q co-deletion are not improved when bevacizumab is added to the standard of care temozolomide, suggest phase II trial findings.

29-06-2018 | Oncology | News | Article

Engineered poliovirus shows potential for treatment of recurrent glioma

A recombinant nonpathogenic polio–rhinovirus chimera has demonstrated promising tolerability and efficacy in patients with recurrent malignant glioma in a phase I trial.

28-02-2018 | Neuro-oncology | News | Article

Oncolytic virus shows promise in recurrent malignant glioma

Treatment with DNX-2401, a tumor-selective adenovirus, can lead to “dramatic responses” and long-term survival in some patients with recurrent malignant glioma, say researchers who conducted a phase I study.

21-02-2018 | Neuro-oncology | News | Article

No event-free survival benefit with bevacizumab in pediatric high-grade glioma

Adding bevacizumab to radiotherapy plus temozolomide does not improve event-free survival in children with newly diagnosed high-grade glioma, trial findings show.

09-02-2018 | Neuro-oncology | News | Article

QoL not diminished by tumor-treating fields therapy for glioblastoma

Adding tumor-treating fields to standard treatment with temozolomide does not negatively affect health-related quality of life in patients with newly diagnosed glioblastoma, an analysis of EF-14 data shows.

image credits